Naltrexone Treatment Centers in New Mexico

Yes. Providers in New Mexico must document a current OUD diagnosis to prescribe naltrexone as part of medication-assisted treatment. The intake assessment typically takes 60–90 minutes and includes a physical exam, drug screen, and psychiatric history — results are used to confirm eligibility.

Free naltrexone treatment is possible in New Mexico for patients who qualify for Centennial Care, are enrolled in State Opioid Response–funded clinics, or use charity-care programs at community behavioral-health centers. Call 988 or 1-800-662-4357 for live referrals.

Yes. Centennial Care covers FDA-approved medications for opioid use disorder, including naltrexone, plus the associated counseling, drug testing, and clinic visits. Specific formulary details (preferred agents, long-acting injectables) vary by plan — check with your Centennial Care managed-care organization.

Call the number on the back of your insurance card and ask: (1) Is {provider name} in-network? (2) What is my mental-health/MAT deductible? (3) What is my copay for MAT visits? Write the reference number from the call for any dispute later.

New Mexico’s Good Samaritan law provides immunity from low-level drug-possession prosecution when someone seeks help for an overdose. MAT enrollment is not penalized; New Mexico specifically prohibits probation or family court from forcing patients to stop naltrexone.

Typically no — New Mexico family and criminal courts increasingly recognize MAT as standard medical care. Longer continuous treatment is often viewed favorably by courts as evidence of stability. Share treatment documentation with your attorney for court proceedings.

Bring a photo ID, insurance or Centennial Care card (if applicable), and a list of current medications. Proof of address and pharmacy information speed up buprenorphine prescribing. Intake staff will walk you through paperwork at your first visit.

First doses are intentionally cautious — 5–10 mg of buprenorphine or 20–30 mg of methadone — to assess tolerance and avoid over-sedation. Your dose is titrated up over the first 1–2 weeks until cravings and withdrawal are controlled.

Buprenorphine and methadone do not test positive on standard 5-panel drug tests — specialty panels are needed. Naltrexone and its metabolites are not screened on standard panels. Share an MAT provider letter with any employer or court drug-testing program to avoid confusion.

Yes. Postpartum continuation of MAT is strongly recommended — overdose risk is elevated in the postpartum period. New Mexico programs increasingly embed MAT within postpartum home-visiting programs to support the mother-infant dyad during the first year.

Patients prescribed buprenorphine or naltrexone in New Mexico can technically receive medication without counseling, but outcomes are significantly better with integrated counseling. Methadone patients at OTPs have counseling requirements per federal rule 42 CFR Part 8.

Under the ADA, you cannot be fired solely because you are enrolled in naltrexone. Current illegal drug use is not protected, but lawful MAT enrollment is. Safety-sensitive roles (CDL, aviation) have additional rules — an employment attorney can review your specific situation.